StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
5
Publishing Date
2023 - 06 - 10
1
2022 - 04 - 14
1
2022 - 02 - 17
1
2021 - 11 - 19
1
2021 - 11 - 04
1
Sector
Manufacturing
5
Tags
Asco
1
Biotech
3
Biotech-bay
1
Car-t
4
Cel
1
Designation
1
Drug
1
Fda
1
Gc012
4
Granted
1
Iot
3
N/a
2
Orphan drug
1
Pre-clinical
1
Preclinical
1
Presentation
1
Regulatory
1
Research
1
Response
1
Results
2
T-cell
3
Therapy
3
Treatment
1
Trial
1
Entities
Gracell biotechnologies inc - adr
5
Symbols
ABBV
6
ABCL
7
ACET
9
ACHL
6
ACLX
4
ADCT
5
ADPT
5
ALLO
16
ALVR
4
ANAB
4
AUTL
15
BLCM
5
BMY
15
BNTX
5
CLLS
13
COYA
6
CRBU
7
CRSP
4
CRVS
7
CTMX
4
CTXR
11
DTIL
10
ENLV
4
EQ
5
FATE
12
FBIO
19
FNCTF
12
GDTC
4
GILD
34
GRCL
5
GSK
4
HARP
8
IBRX
6
IGMS
6
IMMX
7
IMUN
7
INAB
14
INCY
14
JNJ
18
KRBP
8
KYMR
4
LLY
15
LVTX
5
MBIO
21
MRKR
10
NKTR
8
NVS
17
NVSEF
16
ONCT
5
PHIO
6
PSTX
18
RGBP
6
SANA
8
SLS
5
SNGX
15
SNY
16
SNYNF
15
TNXP
5
VIRX
5
XNCR
8
Exchanges
Nasdaq
5
Crawled Date
2023 - 06 - 10
1
2022 - 04 - 14
1
2022 - 02 - 17
1
2021 - 11 - 19
1
2021 - 11 - 04
1
Crawled Time
12:00
1
13:00
2
14:00
1
16:20
1
Source
www.biospace.com
3
www.globenewswire.com
1
www.prnewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
t-cell
symbols :
Grcl
save search
Gracell Biotechnologies Presents Longer-Term Results for FasTCAR-T GC012F in B-Cell Non-Hodgkin’s Lymphoma at EHA2023, Highlighting 100% Overall Response Rate
Published:
2023-06-10
(Crawled : 16:20)
- globenewswire.com
GRCL
|
$10.25
-0.29%
6.4M
|
Manufacturing
|
Email alert
Add to watchlist
gc012
response
results
Gracell Biotechnologies' Abstract on GC012F, a BCMA/CD19 Dual-targeting CAR-T Cell Therapy, Accepted for Presentation at 2022 ASCO Annual Meeting
Published:
2022-04-14
(Crawled : 13:00)
- biospace.com/
GRCL
|
$10.25
-0.29%
6.4M
|
Manufacturing
|
369.5%
|
O:
-0.92%
H:
2.78%
C:
-4.63%
gc012
car-t
presentation
asco
Gracell Biotechnologies Doses First Patients in First-in-Human Clinical Trial Evaluating GC012F, its Dual-Targeting FasTCAR-T Therapy, in B-Cell Non-Hodgkin's Lymphoma
Published:
2022-02-17
(Crawled : 14:00)
- biospace.com/
GRCL
|
$10.25
-0.29%
6.4M
|
Manufacturing
|
172.21%
|
O:
0.53%
H:
2.65%
C:
-5.82%
gc012
car-t
trial
cel
therapy
biotech
iot
t-cell
Gracell Biotechnologies Granted FDA Orphan Drug Designation for FasTCAR-enabled BCMA/CD19 Dual-targeting CAR-T Cell Therapy Candidate GC012F for the Treatment of Multiple Myeloma
Published:
2021-11-19
(Crawled : 12:00)
- biospace.com/
GRCL
|
$10.25
-0.29%
6.4M
|
Manufacturing
|
13.98%
|
O:
21.78%
H:
4.25%
C:
-19.25%
gc012
treatment
fda
orphan drug
therapy
car-t
biotech
drug
iot
granted
t-cell
designation
Gracell Biotechnologies to Present Preclinical Results of TruUCAR-enabled CD19/CD7 Dual-Directed Allogeneic CAR-T Cell Therapy (GC502) for B-Cell Malignancies at the 63rd ASH Annual Meeting
Published:
2021-11-04
(Crawled : 13:00)
- prnewswire.com
GRCL
|
$10.25
-0.29%
6.4M
|
Manufacturing
|
Email alert
Add to watchlist
therapy
car-t
results
biotech
iot
preclinical
t-cell
pre-clinical
Gainers vs Losers
72%
28%
Top 10 Gainers
CZOO
|
$9.98
100.0%
330K
|
AMST
|
$3.48
74.0%
21M
|
Technology Services
CSSE
4
|
$0.2184
43.4%
36M
|
Consumer Services
BW
|
News
|
$1.0002
9.05%
190K
|
Electronic Technology
DXYZ
4
|
$30.91
8.49%
73K
|
n/a
CSGP
|
News
|
$90.34
6.76%
180K
|
Technology Services
BSX
|
$73.35
6.32%
1M
|
Health Technology
ZLAB
|
$16.07
6.28%
28K
|
Health Technology
ALGM
|
$28.08
5.68%
86K
|
Electronic Technology
ALLK
|
$1.1
4.76%
23K
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.